Amgen Australia was established in 1991. The corporate headquarters are located in North Ryde, Sydney, with a second office in Melbourne. Amgen Australia employs over 160 people and currently markets eleven products for the treatment of cancer, kidney disease, bone disease and other serious illnesses.
Amgen Australia is amongst the highest contributing countries to Amgen’s global clinical trial activity and invests approximately $30-35 million in local research and development annually.
Searching for the Answers Within
At Amgen, we believe in a “biology first” approach. We use cutting-edge science and technology to study the subtlest biological mechanisms in search of therapies that will improve the lives of those who suffer from serious diseases. Amgen believes the cure for disease can be found inside each and every one of us.